Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 22
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04093622 | Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy | ||
| NCT04245722 | FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies | ||
| NCT05069935 | FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors | ||
| NCT04629729 | FT819 in Subjects With B-cell Malignancies | ||
| NCT05182073 | FT576 in Subjects With Multiple Myeloma | ||
| NCT05950334 | FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101) | ||
| NCT02354417 | A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies | ||
| NCT04614636 | FT538 in Subjects With Advanced Hematologic Malignancies | ||
| NCT04106167 | Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy | ||
| NCT05395052 | FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors | ||
| NCT03319459 | FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors | ||
| NCT00890500 | Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies. | ||
| NCT06241456 | FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors | ||
| NCT04551885 | FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors | ||
| NCT01527838 | Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit | ||
| NCT01627314 | The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies. | ||
| NCT03841110 | FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors | ||
| NCT04023071 | FT516 in Subjects With Advanced Hematologic Malignancies | ||
| NCT06308978 | FT819 in Moderate to Severe Active Systemic Lupus Erythematosus | ||
| NCT02354443 | A Trial of a Single ProHema-CB Product Transplant in Pediatric Patients With Inherited Metabolic Disorders | ||
| NCT05934097 | FT596 in Combination With R-CHOP in Subjects With B-Cell Lymphoma | ||
| NCT02743351 | Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies |
